U.S. drug developer Capricor places Duchenne drug trial on hold

Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy (DMD), a muscle-wasting disorder, citing a safety review.

from Reuters: Health News https://reut.rs/2QQUsLG
via IFTTT